Provided by Tiger Trade Technology Pte. Ltd.

iBio

1.11
-0.0700-5.93%
Post-market: 1.110.0004+0.04%19:30 EDT
Volume:340.42K
Turnover:387.51K
Market Cap:71.38M
PE:-3.50
High:1.21
Open:1.18
Low:1.10
Close:1.18
52wk High:3.82
52wk Low:0.7811
Shares:64.31M
Float Shares:52.11M
Volume Ratio:0.97
T/O Rate:0.65%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.3175
EPS(LYR):-0.3175
ROE:-65.70%
ROA:-30.80%
PB:0.83
PE(LYR):-3.50

Loading ...

AstraZeneca To Invest $2 Billion In Summit And Co-Develop Drugs; Shares Jump After Hours

Options & Short Sell
·
Sep 29

HC Wainwright Initiates iBio With Buy Rating, $7 Price Target

MT Newswires Live
·
Sep 17

iBio Initiated at Buy by HC Wainwright & Co.

Dow Jones
·
Sep 17

Ibio, Inc. : H.c. Wainwright Initiates Coverage with Buy Rating and Target Price $7

THOMSON REUTERS
·
Sep 17

U.S. Research Roundup-Celcuity, Fluence Energy, Salesforce

Reuters
·
Sep 17

iBio Highlights Breakthrough Antibody Strategy for Obesity

TIPRANKS
·
Sep 15

iBio Announces Annual Shareholder Meeting

Reuters
·
Sep 05

iBio CEO Joins Wells Fargo Annual Healthcare Conference Fireside Chat

Reuters
·
Sep 02

Analyst Warns of Significant Clinical and Regulatory Risks Facing Ibio Inc’s Drug Pipeline

TIPRANKS
·
Aug 31

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Aug 29

iBio Advances IBIO-600 into Phase 1 Multiple-Ascending-Dose Trial Stage After Completing Single-Ascending-Dose Dosing

Reuters
·
Aug 28

iBio FY26 Net Loss Widens to $33.04 Million; Revenue Drops to $100,000

Reuters
·
Aug 28

Ibio Reports Fiscal Year 2026 Financial Results and Provides Corporate Update

THOMSON REUTERS
·
Aug 28

Press Release: iBio Reports Fiscal Year 2026 Financial Results and Provides Corporate Update

Dow Jones
·
Aug 28

iBio Announces 2026 Annual Shareholder Meeting

Reuters
·
Aug 20

iBio appoints Molly Carr as chief medical officer

TIPRANKS
·
Aug 04

iBio Files Form 3 for Chief Medical Officer Molly Carr

Reuters
·
Aug 04

iBio Names Endocrinologist Molly Carr as Chief Medical Officer

Reuters
·
Aug 04

Ibio Strengthens Clinical Leadership with Appointment of Endocrinologist Molly Carr as Chief Medical Officer

THOMSON REUTERS
·
Aug 04

iBio Updates Governance Deadlines for 2026 Annual Meeting

TIPRANKS
·
Jul 18